Literature DB >> 22196739

Preliminary report of Ki-67 reactivity in synovial chondromatosis of the temporomandibular joint: an immunohistochemical study.

Hiroaki Yoshida1, Kaname Tsuji, Nobuyoshi Oshiro, Masahiro Wato, Shosuke Morita.   

Abstract

BACKGROUND: Synovial chondromatosis (SC) is rare benign condition characterized by the formation of metaplastic cartilaginous nodules in the synovial membrane and joint space. Cartilaginous nodules from and may become pedunculated and detached from the synovial membrane, so becoming loose bodies within the joint space.
PURPOSE: The aim of this study was to determine the proliferative activity of loose body and synovial membrane of SC in temporomandibular joint by using Ki-67 antibody.
MATERIAL AND METHODS: We obtained 4 specimens (4 female) of released loose body and 2 specimens of synovial membrane with attached loose bodies by surgical operation. The specimens were fixed in 10% formalin solution, and embedded in paraffin. The immunohistochemical study was carried out using an anti-human Ki-67 monoclonal antibody. The sections were visualized by 3, 3'-diaminobenzidine-tetrahydrochloride (DAB).
RESULTS: The expression of Ki-67 was scarcely detected in all cases of loose bodies. In second phase cases, the mild expression of Ki-67 was detected at both cases of synovial membrane which were attached loose bodies.
CONCLUSION: These results suggested that released loose bodies into the joint compartment did not have independent proliferating activity. However, the synovial membrane may play a very important role in the proliferation of the loose bodies. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Immunohistochemical study; Ki-67; Synovial chondromatosis (SC); Temporomandibular joint (TMJ)

Mesh:

Substances:

Year:  2011        PMID: 22196739     DOI: 10.1016/j.jcms.2011.10.018

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  4 in total

1.  Anesthetic Management of a Patient With Ehlers-Danlos Syndrome.

Authors:  Naohiro Ohshita; Masahiko Kanazumi; Kaname Tsuji; Hiroaki Yoshida; Shosuke Morita; Yoshihiro Momota; Yasuo M Tsutsumi
Journal:  Anesth Prog       Date:  2016

2.  Transforming growth factor beta 3 involved in the pathogenesis of synovial chondromatosis of temporomandibular joint.

Authors:  Yingjie Li; Loaye Abdelaziz El Mozen; Hengxing Cai; Wei Fang; Qinggong Meng; Jian Li; Mohong Deng; Xing Long
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

3.  Synovial chondromatosis of the right side temporomandibular joint extending to the middle cranial fossa: A case report with 7-year postoperative follow up and expression of a biomarker of cell proliferative activity.

Authors:  Hiroyuki Yoshitake; Kou Kayamori; So Wake; Fumiaki Sato; Koji Kino; Kiyoshi Harada
Journal:  Int J Surg Case Rep       Date:  2016-01-25

Review 4.  Synovial chondromatosis of the temporomandibular joint with 400 loose bodies: a case report and literature review.

Authors:  Wenyan Zhao; Yan Ruan; Wentao Zhang; Fan Yang
Journal:  J Int Med Res       Date:  2021-03       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.